These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3723163)

  • 1. Randomized or historical control groups in cancer clinical trials: are historical controls valid?
    Gehan EA
    J Clin Oncol; 1986 Jul; 4(7):1024-5. PubMed ID: 3723163
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative clinical trials with historical controls: a statistician's view.
    Gehan EA
    Biomedicine; 1978 Sep; 28 Spec No():13-9. PubMed ID: 363189
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of randomized concurrent control groups with matched historical control groups: are historical controls valid?
    Diehl LF; Perry DJ
    J Clin Oncol; 1986 Jul; 4(7):1114-20. PubMed ID: 3723167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of data bases and historical controls in treatment comparisons.
    Byar DP
    Recent Results Cancer Res; 1988; 111():95-8. PubMed ID: 3175313
    [No Abstract]   [Full Text] [Related]  

  • 5. Historical controls, data banks, and randomized trials in clinical research: a review.
    Fleming TR
    Cancer Treat Rep; 1982 May; 66(5):1101-5. PubMed ID: 7083214
    [No Abstract]   [Full Text] [Related]  

  • 6. [Controversial viewpoints on the use of historical controls: Is there an all-or-nothing law?].
    Feifel G
    Langenbecks Arch Chir; 1981; 355():399-409. PubMed ID: 7339376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical and conceptual limitations of best conceived randomized trials.
    Israel L
    Biomedicine; 1978 Sep; 28 Spec No():36-9. PubMed ID: 363192
    [No Abstract]   [Full Text] [Related]  

  • 8. Knowledge acquisition in oncology from randomized therapeutic trials.
    Flamant R; Sancho-Garnier H
    Bull Cancer; 1980; 67(4):446-9. PubMed ID: 7225601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to randomized clinical trials.
    Ellison GW; Mickey MR; Myers LW
    Neurology; 1988 Jul; 38(7 Suppl 2):73-5. PubMed ID: 3290718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and specificity of clinical trials. Randomized v historical controls.
    Sacks HS; Chalmers TC; Smith H
    Arch Intern Med; 1983 Apr; 143(4):753-5. PubMed ID: 6838297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials.
    Gail MH
    Cancer Treat Rep; 1985 Oct; 69(10):1107-13. PubMed ID: 4042091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size of phase III cancer clinical trials.
    Simon R
    Cancer Treat Rep; 1985 Oct; 69(10):1087-93. PubMed ID: 4042088
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].
    Byar D; Chastang C
    Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The logistics of clinical trials.
    Bonadonna G; Valagussa P
    Biomedicine; 1978 Sep; 28 Spec No():43-8. PubMed ID: 363195
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperthermia as an adjuvant to radiotherapy. Review of the randomized multicenter studies of the European Society for Hyperthermic Oncology.
    Overgaard J
    Strahlenther Onkol; 1987 Jul; 163(7):453-7. PubMed ID: 3303392
    [No Abstract]   [Full Text] [Related]  

  • 16. Designing and analyzing clinical trials which allow institutions to randomize patients to a subset of the treatments under study.
    Schoenfeld DA; Gelber RD
    Biometrics; 1979 Dec; 35(4):825-9. PubMed ID: 526527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG in the treatment of cancer.
    Can Med Assoc J; 1983 Dec; 129(11):1173-4. PubMed ID: 6357417
    [No Abstract]   [Full Text] [Related]  

  • 18. Historical controls.
    Farewell VT
    Pediatrics; 1982 Jul; 70(1):145-7. PubMed ID: 7088617
    [No Abstract]   [Full Text] [Related]  

  • 19. How to evaluate improvements in cancer treatment: the debate continues.
    Jones SE
    Biomedicine; 1978 Sep; 28 Spec No():55-7. PubMed ID: 363198
    [No Abstract]   [Full Text] [Related]  

  • 20. Designing for nonparametric Bayesian survival analysis using historical controls.
    Van Ryzin J
    Cancer Treat Rep; 1980; 64(2-3):503-6. PubMed ID: 7407791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.